Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
-
+
FP07 - Mesothelioma, Thymoma and Other Thoracic Malignancies
- Type: Posters (Featured)
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
- Presentations: 5
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
FP07.05 - DREAM3R: Durvalumab With Chemotherapy as First Line Treatment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial
00:00 - 00:00 | Author(s): Patrick Forde
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P16 - Immunotherapy (Phase II/III Trials) - First-Line, Advanced NSCLC
- Type: Posters
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 7
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P16.02 - Atezolizumab, Bevacizumab and Chemotherapy (IMpower150) in Stage IV Non-Small Cell Lung Cancer: The Australian Experience
00:00 - 00:00 | Presenter: Samantha Larna Dean
- Abstract
Loading...
-
+
P24 - Liquid Biopsy and Other Non-invasive Diagnostic Modalities - Targeted Therapy
- Type: Posters
- Track: Liquid Biopsy and Other Non-invasive Diagnostic Modalities
- Presentations: 14
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P24.03 - Dynamic Circulating Tumor DNA Interim Results From The ALKternate Clinical Trial
00:00 - 00:00 | Presenter: Malinda Itchins
- Abstract
Loading...
-
+
P47 - Novel Therapeutics and Targeted Therapies - Clinical Trial in Progress
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 18
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P47.12 - ALKternate: A Proof of Concept Study in ALK-Rearranged NSCLC Alternating Lorlatinib With Crizotinib After Disease Progression
00:00 - 00:00 | Presenter: Malinda Itchins
- Abstract
Loading...
-
+
P59 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - Targeted Therapies Biomarkers
- Type: Posters
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
- Presentations: 32
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P59.12 - KRAS Mutation Subtypes in Non-Small Cell Lung Cancer and Clinical Outcomes: A Single Centre Experience
00:00 - 00:00 | Presenter: Alexander Patrick Davis
- Abstract
Loading...
-
+
ES20 - Caveats, Challenges, and Controversies in Immunotherapy of Lung Cancer: Phase II and Phase III Trials*
- Type: Education Session
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 5
*Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.- Moderators:David R. Gandara
- Coordinates: 9/14/2021, 20:30 - 21:05, Program Auditorium
-
+
ES20.03 - Open and Unanswered Questions for Treatment and Needed Studies: What We Do and Do Not Know
20:34 - 20:36 | Presenter: Nick Pavlakis
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.